Printer Friendly

Articles from Physician's Briefings (October 19, 2018)

1-14 out of 14 article(s)
Title Author Type Words
2014 to 2016 Saw 470 Percent Increase in HIV PrEP Use in U.S. ~7 percent of those with indications for PrEP were prescribed PrEP, including 2.1 percent of women. 253
ASA: Dorsal Root Ganglion Stimulation Disrupts Back Pain; Drop in numerical rating scale pain score, ODI for chronic lower extremity, back pain. 241
Aspirin, Anticoagulants Similarly Prevent VTE After TKA; In patients having total knee arthroplasty, aspirin non-inferior for venous thromboembolism, death. 312
Asthma May Raise Obesity Risk Later in Childhood; 3- to 4-year-olds with active asthma, wheezing have increased risk of obesity by age 8. 289
Bioinformatics Tool Can ID Source of Bloodstream Pathogens; Classically non-enteric pathogens identified in gut microbiome, challenging origin of these infections. 194
CDC: First U.S. Case of Rat-Borne Andes Virus Diagnosed; New World hantavirus can present with symptoms similar to those of the flu. 244
CDC: Vaccination Rates More Than 95 Percent for Kindergartners; Coverage could be even higher if schools followed up with under-vaccinated. 236
Light Use of Topical Skin Tx Before Radiotherapy Seems Safe; Radiation dose not impacted with light or moderate use of skin treatments, regardless of beam energy, incidence. 319
Limited Success for Changing Diet and Exercise Among Nurses; At 3 months, significant increase in fruit, vegetable intake but significant decline in physical activity. 232
Physical Therapy an Option for Nonobstructive Meniscal Tears; Physical therapy non-inferior to arthroscopic partial meniscectomy for nonobstructive meniscal tears. 275
Poor Experience With PCP Linked to Hospitalization in CKD; Risk of hospitalization up for Hispanic patients with lower scores on Ambulatory Care Experiences Survey. 232
Transcatheter Mitral Valve Repair Benefits Some With Heart Failure; For patients with secondary mitral regurgitation who remain symptomatic despite medical therapy. 260
Triple Combo Regimens May Address Cause of Cystic Fibrosis; Promising results for VX-659-, VX-445-tezacaftor-ivacaftor for cystic fibrosis with mutations in CFTR. 319
Variability in Geographic Availability of New Antibiotics; Greater geographic availability for antibiotics from and/or marketed by companies in U.S., Europe. 237

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |